Rushi Life Sciences Private Limited
Pharmaceutical manufacturing company based in Telangana, established in 2019.
2019 | Hyderabad, Telangana (India) | Active
Rushi Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth -5.41%
- Ebitda 97.02%
- Net Worth -3.32%
- Total Assets 3.26%
About Rushi Life Sciences
Rushi Life Sciences Private Limited (RLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 March 2019 (Five years and 11 months 17 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Revathi Chamarthi and Sri Singareddy serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24230TG2019PTC131272
- Company No.
131272
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Who are the key members and board of directors at Rushi Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Revathi Chamarthi  | Director | 14-Mar-2019 | Current |
| Sri Singareddy | Director | 14-Mar-2019 | Current |
Financial Performance of Rushi Life Sciences.
Rushi Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 5.41% decrease in profit. The company's net worth dipped by a decrease of 3.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rushi Life Sciences?
Unlock access to Rushi Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Csr Life Sciences Private LimitedSri Singareddy is a mutual person
- Grocal Greens Llp
Revathi Chamarthi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rushi Life Sciences?
Unlock and access historical data on people associated with Rushi Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rushi Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rushi Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
